FIELD: biotechnologies.
SUBSTANCE: invention refers to a derivative of peptides PYY or PP or their equivalent modified with one or more side chains bound with serum albumin and containing distal tetrazole group or carboxylic acid group. Besides, the invention refers to their compositions and treatment methods of states susceptible to modulation of Y receptors.
EFFECT: improvement of composition properties.
13 cl, 12 dwg, 15 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID SALT AND LUBRICANT | 2019 |
|
RU2807183C2 |
| POLYPEPTIDES | 2012 |
|
RU2669999C2 |
| SOLID COMPOSITIONS CONTAINING AGONIST TO GLP AND SALT OF N-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2011 |
|
RU2600440C2 |
| SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID SALT | 2019 |
|
RU2804318C2 |
| SELECTIVE COMPOUNDS OF YY PEPTIDE AND USE THEREOF | 2016 |
|
RU2726777C2 |
| FGF21 DERIVATIVES WITH ALBUMIN BINDING AGENT A-B-C-D-E- AND THEIR APPLICATION | 2010 |
|
RU2525393C2 |
| GLP-1 PEPTIDES COMPOSITIONS AND THEIR PRODUCTION | 2013 |
|
RU2641198C2 |
| ACYLATED GLP-1 COMPOUNDS | 2006 |
|
RU2434019C2 |
| GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DERIVATIVES | 2004 |
|
RU2401276C2 |
| NOVEL GLUCAGON ANALOGUES | 2012 |
|
RU2610175C2 |
